Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 2/2007

Open Access 01-02-2007 | Editorial

Confusing Inequitable Medicare Prescription Drug Benefit

Author: Gail E. Shearer, MPP

Published in: Journal of General Internal Medicine | Issue 2/2007

Login to get access

Excerpt

Medicare beneficiaries enrolling in the new prescription drug coverage plans found that along with the financial relief came a dizzying array of choices inequities that result in very different coverage options and prices depending on where they live. This does not have to be the case. Taxpayers who foot 75% of the bill deserve the benefit of leveraging of public purchasing power. Medicare beneficiaries deserve a prescription drug option they can understand, that is uniform nationwide, that meets unexpected needs, and that achieves deep drug discounts. …
Literature
1.
Schwartz B. The paradox of choice—why more is less, Harper-Collins, 2004:26.
2.
Scitovsky T. Ignorance as a source of oligopoly power. Am Econ Rev. 1950;40(2):48–53.
3.
4.
Rice T, Thomas K. Evaluating the new Medigap Standardization Regulations. Health Aff. 1992;Spring:11(1)194–207.CrossRef
5.
Fox PD, Snyder R, Dallek G, Rice T. Should Medicare HMO benefits be standardized?” Health Aff. 1999;18(4):40–52.CrossRef
6.
Biles B, Adrion E. Payments to Medicare Advantage Plans Exceed Fee-for-Service Costs: Options for Medicare Savings from 2007 through 2011. Washington: George Washington University School of Public Health & Health Services; September 15, 2006.
7.
8.
Wennberg JE, Fisher ES, Skinner JS. Geography And The Debate Over Medicare Reform, Health Affairs, Web Exclusive, February 13, 2002.
9.
10.
11.
Hartung DM, Ketchum KL, Haxby DG. An Evaluation of Oregon’s Evidence-Based Practitioner-Managed Prescription Drug Plan. Health Affairs. 2006;25(5) September/October.
12.
13.
Metadata
Title
Confusing Inequitable Medicare Prescription Drug Benefit
Author
Gail E. Shearer, MPP
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 2/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-006-0080-5

Other articles of this Issue 2/2007

Journal of General Internal Medicine 2/2007 Go to the issue

Original Article

Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment

Original Article

Physician Practice Patterns and Variation in the Delivery of Preventive Services

Original Article

Physicians and Drug Representatives: Exploring the Dynamics of the Relationship

Health Policy

Variation in Estimated Medicare Prescription Drug Plan Costs and Affordability for Beneficiaries Living in Different States

Updates

Update in HIV Care

Original Article

Measuring Patient and Clinician Perspectives to Evaluate Change in Health-Related Quality of Life Among Patients with Chronic Obstructive Pulmonary Disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits